Cosmetic cross-reference Noindex: medium evidence

Guaiol

CAS 489-86-1

Guaiol (CAS 489-86-1) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Guaiol

CAS Number

489-86-1

UNII

I7WP008A91

InChIKey

TWVJWDMOZJXUID-SDDRHHMPSA-N

ChEMBL ID

CHEMBL226915

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Guaiol used for in pharmaceutical contexts?

Guaiol (CAS 489-86-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Guaiol?

No adverse-event association or SIDER side-effect rows are rendered for Guaiol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Guaiol also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for OCTAHYDRO-3,8-DIMETHYLAZULEN-5-YLPROPAN-2-OL with EU status "permitted".

What clinical phase is Guaiol in?

No phase 1-4 clinical development badge is rendered for Guaiol because the matched compound identifier rows do not contain a max-phase value.